John Wilkin
Stock Analyst at Craig-Hallum
(2.87)
# 1,475
Out of 5,090 analysts
5
Total ratings
60%
Success rate
48.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $7.20 | +66.67% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $14.75 | +1.69% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $44.61 | +0.87% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $9.56 | -16.32% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $7.09 | +309.03% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $7.20
Upside: +66.67%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $14.75
Upside: +1.69%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $44.61
Upside: +0.87%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $9.56
Upside: -16.32%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $7.09
Upside: +309.03%